Immunonkologie «Coming of Age» - die nächste Generation der Immun-Checkpoint-Inhibitoren

Publisher： Karger

E-ISSN： 2296-5262|37|4|6-9

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.4, 2014-09, pp. : 6-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Die nächste Generation ist verantwortlich

By Graf-Baumann T.  

Manuelle Medizin, Vol. 44, Iss. 3, 2006-06 ,pp. : 169-170

Springer Publishing Company

Access to resources Recommend Favorite

Zelluläre Immuntherapien als Kombinationspartner für die Immun-Checkpoint-Blockade

By  

Oncology Research and Treatment, Vol. 37, Iss. 4, 2014-09 ,pp. : 14-15

Karger

Access to resources Recommend Favorite

Rationale, Visionen und Grenzen der Immunonkologie: Checkpoint-Inhibition als neue Therapiesäule der Tumortherapie

By  

Oncology Research and Treatment, Vol. 38, Iss. 3, 2015-04 ,pp. : 2-5

Karger

Access to resources Recommend Favorite

Welche Chancen bietet die Immunonkologie für ein indikationsübergreifendes Langzeitüberleben?

By  

Oncology Research and Treatment, Vol. 38, Iss. 3, 2015-04 ,pp. : 6-11

Karger

Access to resources Recommend Favorite

The Baby Boom: Coming of Age?

By Pollard Nick  

The British Journal of Occupational Therapy, Vol. 69, Iss. 6, 2006-06 ,pp. : 247-247

College of Occupational Therapists

Access to resources Recommend Favorite